Reversing Aging? The Science of Cellular Reprogramming & Senolytics (Sinclair, Yamanaka)

Aging is no longer seen as inevitable, but as a biological process we might one day treat. Groundbreaking work by Dr. David Sinclair (Harvard) and Dr. Shinya Yamanaka (Nobel Laureate) is revealing how epigenetic reprogramming and senolytic therapies could reset the body’s biological clock, extending not just lifespan, but healthspan. In this video, we explore: 🧬 Cellular senescence: How “zombie cells” drive inflammation and age-related disease 💊 Senolytics: Drugs like dasatinib + quercetin that clear senescent cells, extending healthspan in mice 🔄 Partial reprogramming: Using Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) to reverse epigenetic age, without erasing cell identity 👁️ Landmark experiment: Blind mice regaining vision through epigenetic reset (Sinclair Lab, 2020) 🔋 NAD+ and sirtuins: How declining NAD+ accelerates aging—and why precursors like NMN and NR are being tested in humans ⚠️ Challenges: Cancer risk, delivery methods, and the gap between biomarkers and real-world longevity This isn’t about immortality. It’s about compressing morbidity—living healthier for longer, free from chronic disease. 🔬 Key References: Takahashi & Yamanaka (2006). Induction of Pluripotent Stem Cells. Cell Lu et al. (2020). Reprogramming to recover youthful epigenetic information. Nature Sinclair, D. (2019). Lifespan: Why We Age, and Why We Don’t Have To ClinicalTrials.gov: Senolytic trials (NCT04313634, NCT04210986) 👍 Like if you believe aging can be treated as a disease 🔔 Subscribe for deep, science-backed insights into longevity, biotech, and human potential 💬 Comment: Should we treat aging itself, or just its diseases? #Longevity #Aging #Senolytics #DavidSinclair #Yamanaka #EpigeneticReprogramming #NAD #NMN #Healthspan #Geroscience #CellularSenescence #Rejuvenation #Biotech #AntiAging #Science